IRIS - Res&Arch Institutional Research Information System - Research & Archive

IRACI, NUNZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.054
EU - Europa 1.652
AS - Asia 947
SA - Sud America 130
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 4.798
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.033
UA - Ucraina 358
SG - Singapore 307
IE - Irlanda 289
SE - Svezia 228
HK - Hong Kong 221
VN - Vietnam 211
IT - Italia 207
RU - Federazione Russa 186
BR - Brasile 128
CN - Cina 123
DE - Germania 98
FI - Finlandia 92
GB - Regno Unito 87
TR - Turchia 47
BE - Belgio 35
FR - Francia 17
AT - Austria 13
CA - Canada 10
CH - Svizzera 10
NL - Olanda 9
PL - Polonia 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 5
IN - India 5
MX - Messico 5
RO - Romania 5
CI - Costa d'Avorio 4
EU - Europa 4
IQ - Iraq 4
BD - Bangladesh 3
JP - Giappone 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KR - Corea 2
MA - Marocco 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AM - Armenia 1
BZ - Belize 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SN - Senegal 1
UY - Uruguay 1
Totale 4.798
Salva come PNG Salva come JPEG
Città #
Chandler 349
Dublin 288
Singapore 220
Hong Kong 215
Dong Ket 211
Jacksonville 190
San Mateo 180
Perugia 103
Boardman 98
Santa Clara 85
Medford 77
Princeton 76
Andover 65
Fremont 64
Moscow 59
Wilmington 54
Dearborn 52
Ashburn 50
Ann Arbor 48
Beijing 45
The Dalles 44
Izmir 40
Altamura 35
Brussels 34
Lawrence 30
Norwalk 23
Saint Petersburg 23
West Jordan 20
Des Moines 15
São Paulo 15
San Giustino 13
Helsinki 12
Los Angeles 11
Redmond 10
Dallas 9
Falls Church 9
Nanjing 9
Auburn Hills 7
Philadelphia 7
Simi Valley 7
Warsaw 7
Munich 6
New York 6
Redwood City 6
Rome 6
San Diego 6
Shanghai 6
Toronto 6
Brasília 5
Den Haag 5
Hefei 5
Lappeenranta 5
San Paolo di Civitate 5
Spoleto 5
Woodbridge 5
Zhengzhou 5
Abidjan 4
Belo Horizonte 4
Brooklyn 4
Houston 4
Mcallen 4
Turku 4
Vienna 4
Atlanta 3
Chengdu 3
Columbus 3
Goiânia 3
Hebei 3
Kunming 3
Nanchang 3
Ottawa 3
Recife 3
Salvador 3
San Francisco 3
Tokyo 3
Alameda 2
Basra 2
Bratislava 2
Buffalo 2
Camerino 2
Charlotte 2
Chicago 2
Denver 2
Fairfield 2
Frankfurt Am Main 2
Guangdong 2
Guangzhou 2
Jinan 2
Joinville 2
João Monlevade 2
Laredo 2
London 2
Mexico City 2
Nantong 2
Nova Iguaçu 2
Nürnberg 2
Panama City 2
Ribeirão Preto 2
Rio de Janeiro 2
Romola 2
Totale 3.105
Salva come PNG Salva come JPEG
Nome #
1,3-DIIDRO-BENZIMIDAZOLONI ANALOGHI: PROGETTAZIONE, SINTESI E SAR DI NUOVI INIBITORI NON-NUCLEOSIDICI DELL’RT 268
1,3-Diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 268
beta-CYCLODEXTRIN HINDERS PLGA PLASTICIZATION DURING MICROPARTICLE MANUFACTURING 148
Prion protein ligands as therapeutic agents for neurodegenerative disorders 117
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 88
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity 88
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 87
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 83
A New 3D Pharmacophore Model for HIV-1 Integrase Strand Transfer Inhibitors 81
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 81
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 80
A refined pharmacophore model and optimization of 1H-benzylindole HIV-1 integrase inhibitors 77
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 76
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non–Nucleoside reverse Transcriptase Inhibitors 75
From 3D-pharmacophore models to synthetic route towards anti-HIV agents 75
Design and synthesis of NR2B Subtype-Selective Antagonist 75
Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 74
Nuovi antagonisti non-competitivi del recettore NMDA/NR2B:design and sintesi 73
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 72
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 72
Binding Mode Prediction of Strand Transfer HIV-1 Integrase Inhibitors Using Tn5 Transposase as a Plausible Surrogate Model for HIV-1 Integrase 71
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 69
Improvement of water solubility of non-competitive AMPA receptor antagonists by complexation with beta-cyclodextrin. 68
A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model. 67
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 67
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 67
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 66
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 66
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 65
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 65
Diselenides and benzisoselenazolones as antiproliferative agents and glutathione-S-transferase inhibitors 64
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 62
DECODING THE FUNCTION OF THE N-TERMINAL TAIL OF THE CELLULAR PRION PROTEIN TO INSPIRE NOVEL THERAPEUTIC AVENUES FOR NEURODEGENERATIVE DISEASES 62
Exploration of the binding mode of HIV-1 integrase strand transfer inhibitors through different computational approaches. 61
Sviluppo di modello farmacoforico predittivo per gli NR2B antagonisti del recettore NMDA 61
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 60
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 58
Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 56
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 55
HIV-1-IN Strand-Transfer Inhibitors: phenyl ring exploration and synthesis of 1H-benzylindole derivative through fluorine substitutions 54
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 54
Nuovo modello farmacoforico per inibitori dell’Integrasi dell’HIV-1: ottimizzazione della potenza di composti a struttura 1H-benzilindolica 53
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 53
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series. 53
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 52
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 52
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 51
New chemotypes to fight HCV infection: discovery of selective inhibitors of HCV replication with pyrazolobenzothiazine scaffold 51
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 51
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 51
Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication 51
Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’ HIV-1 Mediante Tecniche di Virtual screening. 50
Tn5 Transposase as a useful platform to simulate HIV-1 Integrase inhibitor binding mode 50
Studi Computazionali per l’Identificazione di Nuovi Inibitori Non-Nucleosidici della Trascrittasi Inversa dell’HIV- 49
Nuovi chemotipi di inibitori dell'HCV NS5B polimerasi 49
Docking studies on a new HIV integrase–Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 49
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 48
Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors. ChemMedChem 47
INTEGRASE STRAND TRANSFER INHIBITORS (INSTIs): SYNTHESIS AND ANTIVIRAL EFFETCS OF CHLORO-FLUORO SUBSTITUTIONS 46
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 46
Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors. 46
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 44
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 44
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. 43
Pharmacophore Modeling, Docking Experiments And Discovery Of New HIV-1 NNRTIs. 42
Progettazione, sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 41
Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 41
Response of a simian immunodeficiency virus (SIVmac251) to raltegravir: a basis for a new treatment for simian AIDS and an animal model for studying lentiviral persistence during antiretroviral therapy. 40
Rational design, synthesis and SAR of 1,3-dihydro- benzimidazolone analogues as new anti-HIV agents 39
NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors 38
Pharmacological agents targeting the cellular prion protein 38
Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. 37
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 37
NCp7: Targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders 35
Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. 35
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 31
L-arginine improves solubility and anti sars-cov-2 mpro activity of rutin but not the antiviral activity in cells 24
Totale 4.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 0 0 0 0 0 0 41
2020/2021882 10 57 25 49 201 77 59 5 94 26 56 223
2021/2022708 16 135 12 37 47 7 5 231 27 15 88 88
2022/2023989 82 141 15 91 82 109 0 56 356 2 33 22
2023/2024481 36 62 23 11 5 8 73 35 63 29 68 68
2024/2025972 2 104 27 107 99 12 76 25 197 98 159 66
Totale 4.983